Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Targeted therapies in systemic lupus erythematosus: successes, failures and future.

Hahn BH.

Ann Rheum Dis. 2011 Mar;70 Suppl 1:i64-i66. doi: 10.1136/ard.2010.142208. Review.

PMID:
21339222
2.

B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.

Harvey PR, Gordon C.

BioDrugs. 2013 Apr;27(2):85-95. doi: 10.1007/s40259-013-0015-8.

PMID:
23456653
3.

Belimumab: review of use in systemic lupus erythematosus.

Boyce EG, Fusco BE.

Clin Ther. 2012 May;34(5):1006-22. doi: 10.1016/j.clinthera.2012.02.028. Epub 2012 Mar 30. Review.

PMID:
22464040
4.

[Allergo-immunology. Clinical immunology].

Chizzolini C.

Rev Med Suisse. 2012 Jan 11;8(323):11-3. French.

PMID:
22303732
5.

Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.

Dooley MA, Houssiau F, Aranow C, D'Cruz DP, Askanase A, Roth DA, Zhong ZJ, Cooper S, Freimuth WW, Ginzler EM; BLISS-52 and -76 Study Groups..

Lupus. 2013 Jan;22(1):63-72. doi: 10.1177/0961203312465781.

PMID:
23263865
6.

Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

Dall'Era M.

Curr Opin Rheumatol. 2011 Sep;23(5):454-8. doi: 10.1097/BOR.0b013e328349a1e5. Review.

PMID:
21720247
7.

Belimumab: targeted therapy for lupus.

Chugh PK, Kalra BS.

Int J Rheum Dis. 2013 Feb;16(1):4-13. doi: 10.1111/1756-185x.12002. Epub 2012 Oct 19. Review.

PMID:
23441766
8.

[What's new in internal medicine: emerging treatments for systemic lupus erythematosus].

Hachulla É.

Ann Dermatol Venereol. 2011 Dec;138 Suppl 4:S241-4. doi: 10.1016/S0151-9638(11)70097-7. Review. French.

PMID:
22202645
9.

Targeted B cell therapies in the treatment of adult and pediatric systemic lupus erythematosus.

Hui-Yuen JS, Nguyen SC, Askanase AD.

Lupus. 2016 Sep;25(10):1086-96. doi: 10.1177/0961203316652491. Review.

PMID:
27497253
10.

Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.

Dall'era M, Chakravarty EF.

Curr Rheumatol Rep. 2011 Aug;13(4):308-16. doi: 10.1007/s11926-011-0186-6. Review.

11.

Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.

Yahya F, Jasmin R, Ng CT, Cheah TE, Sockalingam S.

Int J Rheum Dis. 2013 Dec;16(6):724-30. doi: 10.1111/1756-185X.12179. Epub 2013 Oct 14.

PMID:
24119227
12.

[Statement on the use of mycophenolate mofetil for systemic lupus erythematosus].

Aringer M, Fischer-Betz R, Hiepe F; Kommission Pharmakotherapie der DGRh.; Germany Society of Rheumatology..

Z Rheumatol. 2013 Aug;72(6):575-80. doi: 10.1007/s00393-013-1213-y. German.

PMID:
23756593
13.

Efficacy and safety of biologic therapies for systemic lupus erythematosus treatment: systematic review and meta-analysis.

Borba HH, Wiens A, de Souza TT, Correr CJ, Pontarolo R.

BioDrugs. 2014 Apr;28(2):211-28. doi: 10.1007/s40259-013-0074-x. Review.

PMID:
24190520
14.

Belimumab for the treatment of systemic lupus erythematosus.

Jordan N, D'Cruz DP.

Expert Rev Clin Immunol. 2015 Feb;11(2):195-204. doi: 10.1586/1744666X.2015.996550. Epub 2014 Dec 29. Review.

PMID:
25543845
15.

Mycophenolate mofetil and systemic lupus erythematosus: an overview.

Pisoni CN, Karim Y, Cuadrado MJ.

Lupus. 2005;14 Suppl 1:s9-11. Review.

PMID:
15803925
16.

Biologic therapies in systemic lupus erythematosus.

Bernal CB, Zamora LD, Navarra SV.

Int J Rheum Dis. 2015 Feb;18(2):146-53. doi: 10.1111/1756-185X.12490. Review.

PMID:
25884458
17.
18.

Systemic lupus erythematosus: an update on current pharmacotherapy and future directions.

Touma Z, Urowitz MB, Gladman DD.

Expert Opin Biol Ther. 2013 May;13(5):723-37. doi: 10.1517/14712598.2013.764411. Epub 2013 Jan 23. Review.

PMID:
23339281
19.

Why targeted therapies are necessary for systemic lupus erythematosus.

Durcan L, Petri M.

Lupus. 2016 Sep;25(10):1070-9. doi: 10.1177/0961203316652489. Review.

PMID:
27497251
20.

Current role of rituximab in systemic lupus erythematosus.

Mok CC.

Int J Rheum Dis. 2015 Feb;18(2):154-63. doi: 10.1111/1756-185X.12463. Epub 2014 Dec 19. Review.

PMID:
25522652

Supplemental Content

Support Center